576
Views
6
CrossRef citations to date
0
Altmetric
Endometriosis: Still an Enigmatic Disease

Endometriosis – a decade later – still an enigmatic disease. What is the new in the diagnosis and treatment?

&
Pages 104-108 | Received 01 Feb 2019, Accepted 28 Sep 2019, Published online: 12 Oct 2019

References

  • Abbas S, Ihle P, Koster I, et al. Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis- symptoms: finding from a statutory health insurance-based cohort in Germany. Eur J Obstet Gynecol Reprod Biol. 2012;160(1):79–83.
  • Meuleman C, Vandenabeele B, Fieuws S, et al. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009;92(1):68–74.
  • Facchin F, Barbara D, Dridi D, et al. Mental health in women with endometriosis: searching for predictors of psychological distress. Hum Reprod. 2017;32:855–1861.
  • Vannuccini S, Lazzeri L, Orlandini C, et al. Mental health, pain symptoms and systemic comorbidities in women with endometriosis: a cross sectional study. J Psychosom Obstet Gynaecol. 2017;21:1–6.
  • Sourial S, Tempest N, Hapangama DK. Theories on the pathogenesis of endometriosis. Int J Reprod Med. 2014;2014:179515.
  • Kajihira H, Yamada Y, Kanayama S, et al. New insights into the pathology of endometriosis: from chronic inflammation to danger signal. Gynecol Endocrinol. 2011;27:73–79.
  • Konrad L, Dietze R, Kudipudi PK, et al. Endometriosis I MRKH cases as a proof for the coelomic metaplasia hypothesis?. Reproduction. 2019;1:pii: REP-19-0106.
  • Ibrahi MG, Delarue E, Abesadze E, et al. Abdominal wall endometriosis: myofibroblast as a possible evidence of metaplasia: a case report. Gynecol Obstet Invest. 2017;82:96–101.
  • Fauser BC, Laven JB, Tarlatzis BC, et al. Sex steroid hormones and reproductive disorders: impact on women’s health. Reprod Sci. 2011;18(8):702–712.
  • Lu J, Wang Z, Cao J, et al. A novel and compact review on the role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2018;16(1):80–85.
  • Shang T, De Carolis C, Man GCW, et al. The link between immunity, autoimmunity and endometriosis: a literature update. Autoimmun Rev. 2018;17:945–955.
  • Symons LK, Miller JE, Kay VR, et al. The immunopathology of endometriosis. Trends Mol Reprod. 2018;24(9):748–762.
  • Taniguchi F, Kaponis A, Izawa M, et al. Apoptosis and endometriosis. Front Biosci. 2011;3:648–662.
  • Cho YL, Lee JE, Park MJ, et al. Bufalin suppresses endometriosis progression by inducing pyroptosis and apoptosis. J Endocrinol. 2018;237(3):255–269.
  • Deiana D, Gessa S, Anardu M, et al. Genetics of endometriosis: a comprehensive review. Ginecol Endocrinol. 2019;25:1–6.
  • Vassilopoulou L, Matalliotakis M, Zervou MI, et al. Defining the genetic profile of endometriosis. Exp Ther Med. 2019;17(5):3267–3281.
  • Yao M, Hu T, Wang Y, et al. Polychlorinated biphenyls and its potential role in endometriosis. Environ Pollut. 2017;229:837–845.
  • Zondervan KT, Rahmioglu N, Morris AP, et al. Beyond endometriosis GWAS: genomics to phenomics to the patient. Semin Reprod Med. 2016;34:242–254.
  • Mafra F, Mazzotti D, Pellegrino R, et al. Copy number variation analysis reveals additional variants contributing to endometriosis development. J Assist Reprod Genet. 2017;34(1):117–124.
  • Cousins FL, Xiao L, Gargett CE. Adult stem cells in the pathogenesis and treatment of endometriosis. J Endomet Pelvic Pain dis. 2017;9(4):223–231.
  • Zhou WJ, Yang HL, Shao J, et al. Anti-inflamatory cytokines in endometriosis. Cell Mol Life Sci. 2019;76(11):2111–2132.
  • Khan KN, Fujishita A, Hiraki K, et al. Bacterial contamination hypothesis: a new concept in endometriosis. Reprod Med Biol. 2018;17(2):125–133.
  • Sanchez AM, Vanni VS, Bartiromo L, et al. Is the oocyte quality affected by endometriosis? A review of the literature. J Ovarian Res. 2017;10(1):1–11.
  • Xu B, Guo N, Zhang X, et al. Oocyte quality is decreased in women with minimal or mild endometriosis. Sci Rep. 2015;5:10779.
  • Buggio L, Roncella E, Somigliana E, et al. Vitamin D and benign gynaecological diseases: a critical analysis of the current evidence. Gynecol Endocrinol. 2016;32(4):259–263.
  • Zafrakas M, Grimbizis G, Timologou A, et al. Endometriosis and ovarian cancer risk: a systematic review of epidemiological studies. Front Surg. 2014;8:1–14.
  • Taniguchi F. New knowledge and insights about the malignant transformation of endometriosis. J Obstet Gynaecol Res. 2017;43(7):1093–1100.
  • Saswat L, Ayansina D, Cooper KG, et al. Impact of endometriosis on risk of further gynecological surgery and cancer: a national cohort study. BJOG. 2018;125:64–72.
  • American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis 1996. Fertil Steril. 1997;67:822–829.
  • Tuttlies F, Keckstein J, Ulrich U, et al. ENZIAN-score, a classification of deep infiltrating endometriosis. Zentralbl Gynakol. 2005;127(05):275–281.
  • Koninckx PR, Ussia A, Adamyan L, et al. An endometriosis classification, designed to be validated. Gynecol Surg. 2011;8(1):1–6.
  • Adamson GD, Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril. 2010;94(5):1609–1615.
  • Tomassetti C, Geysenbergh B, Meuleman C, et al. External validation of the endometriosis fertility index (EFI) staging system for predicting non-ART pregnancy after endometriosis surgery. Hum Reprod. 2013;28(5):1280–1288.
  • Boujenah J, Bonneau C, Hugues JN, et al. External validation of the Endometriosis Fertility Index in French population. Fertil Steril. 2015;104(1):119–123.
  • Johnson NP, Hummelshoj L, Adamson GD, et al. World Endometriosis Society consensus on the classification of endometriosis. Hum Reprod. 2017;32(2):315–324.
  • Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412.
  • Rafique S, Decherney AH. Medical treatment of endometriosis. Clin Obstet Gynecol. 2017;60(3):485–496.
  • Howard FM. Surgical treatment of endometriosis. Obstet Gynecol Clin North Am. 2011;38(4):677–686.
  • Surrey ES. Endometriosis and assisted reproductive technologies: maximizing outcomes. Semin Reprod Med. 2013;31:154–163.
  • Brown J, Crawford TJ, Datta S, et al. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev. 2018;5:CD001019.
  • Brown J, Kives S, Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cohrane Database Syst Rev. 2012;3:CD002122.
  • Romer T. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice. Arch Gynecol Obstet. 2018;298:747–753.
  • Grandi G, Mueller M, Bersinger NA. Does dienogest influence the inflammatory response of endometriotic cells? A systematic revive. Inflamm Res. 2016;66:183–192.
  • Nirigianakis K, Grand G, McKinnon B, et al. Dienogest mediates midkine suppression in endometriosis. Hum Reprod. 2016;31:1981–1986.
  • Kolhdouz Mohammadi R, Arablou T. Resveratrol and endometriosis: in vitro and animal studies and underlying mechanisms. Biomed Pharmacother. 2017;91:220–228.
  • Dull AM, Moga MA, Dimienescu OG, et al. Therapeutic approaches of resveratrol on endometriosis via anti-inflammatory and anti-angiogenic pathways. Molecules. 2019;24(4):667.
  • da Silva DM, Gross LA, de Paula Guedes Neto E, et al. The use of resveratrol as an adjuvant treatment of pain in endometriosis: a randomized clinical trial. J Endoc Soci. 2017;1:359–369.
  • Kiani K, Rudzitis-Auth J, Scheuer C, et al. Callionum comosum (Escanbil) extract exerts anti-angiogenic, anti-proliferative and anti-inflammatory effects on endometriotic lesions. J Ethnopharmacol. 2019;26:239–245.
  • Surrey E, Giudice LC, Lessey BA, et al. Use of elagolix for the management of endometriosis-associated pain: secondary efficacy results from two randomized, placebo-controlled studies. Fertil Steril. 2016;106(3): e268–e269.
  • Bedaiwy MA, Sukifah A, Yong P, Casper R. New developments in the medical treatment of endometriosis. Feril Steril. 2017;107:555–565.
  • Ferrero S, Barra F, Maggiore LR. Current and emerging therapeutics for the management of endometriosis. Drugs. 2018;78(10):995–2012.
  • Duffy JM, Arambage K, Correa FJ, et al. Laparoscopic surgery for endometriosis. Cohrane Database Syst Rev. 2014;3:CD011031.
  • Singh SS, Suen MW. Surgery for endometriosis: beyond medical therapies. Fertile Steril. 2017;107(3):549–554.
  • Nickkho-Amiry M, Savant R, Majumder K, et al. The effect of surgical management of endometrioma on the IVF/ICSI outcomes when compared with no treatment? A systematic review and meta-analysis. Arch Gynecol Obstet. 2018;297:1043–1057.
  • Angioni S, Pontis A, Cela V, et al. Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study. Gynecol Endocrinol. 2015;31(6):454–457.
  • Hamadan M, Duselman G, Li TC, et al. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015;21:809–825.
  • Soto E, Luu TH, Magrina JF, et al. Laparoscopy vs Robotic Surgery for Endometriosis (LAROSE): a multicenter, randomized, controlled trial. Fertli Steril. 2017;107(4):996–1002.
  • Berlanda N, Frattaruolo MP, Aimi G, et al. “Money for nothing”. The role of robotic-assisted laparoscopy for the treatment of endometriosis. Reprod Biomed Online. 2017;35(4):435–444.
  • Donnez O, Roman H. choosing the right surgical techinique for deep endoemtriosis: shaving, disc excision, or bowel resection? Fertil Steril. 2017;108(6):931–942.
  • Delbos L, Bouet PE, Catala L, et al. Surgery using plasma energy for deep endometriosis: a quality of life assessment. J Gynecol Obstet Hum Reprod. 2018;47(8):359–364.
  • Han K, Seo SK, Kim MD, et al. Catheter-directed sclerotherapy for ovarian endoemtrioma: short-term outcomes. Radiology. 2018;289(3):854–859.
  • Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in-vitro fertilization. Fertil Steril. 2002;120:1308–1320.
  • Hamdan M, Omar SZ, Dunselman G, et al. Influence of endometriosis on assisted reproductive technology: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(1):79–88.
  • Senapati S, Sammel MD, Morse C, et al. Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the Society for Assisted Reproductive Technologies Database. Fertil Steril. 2016;106(1):164–171.
  • Carrillo L, Seidman DS, Cittadini E, et al. The role of fertility preservation in patients with endometriosis. J Assist Reprod Genet. 2016;33(3):317–323.
  • Somigliana E, Vigano P, Filippi F, et al. Fertility preservation in women with endometriosis: for all, for some, for none? Hum Reprod. 2015;30(6):1280–1286.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.